These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 3206329

  • 1. [Visualizing muscular phosphorus metabolites in peripheral arterial occlusive disease].
    Rexroth W, Semmler W, Gückel F, Stadtlander M, von Kaick G, Hild R.
    Vasa Suppl; 1988; 23():115-20. PubMed ID: 3206329
    [No Abstract] [Full Text] [Related]

  • 2. [In vivo 31-phosphorus MR spectroscopy of the calf musculature in arterial occlusive diseases].
    Melchert UH, Brinkmann G, Förger K, Gleim M, Wunsch-Binder F, Maier C, Zick G.
    Rofo; 1992 Apr; 156(4):346-52. PubMed ID: 1571516
    [Abstract] [Full Text] [Related]

  • 3. [Phosphorus-31 NMR spectrometry of the calf muscles in patients with arterial claudication. Preliminary results].
    Le Bas JF, Reutenauer H, Franco A, Magne JL, Benabid AL.
    J Mal Vasc; 1987 Apr; 12(1):70-7. PubMed ID: 3559414
    [Abstract] [Full Text] [Related]

  • 4. [Muscular energetics studied by nuclear magnetic resonance spectroscopy of phosphorus (cardiac and skeletal muscles)].
    Rossi A.
    Arch Int Physiol Biochim; 1988 Sep; 96(4):A393-409. PubMed ID: 2463818
    [No Abstract] [Full Text] [Related]

  • 5. Muscle metabolism during exercise in patients with occlusive arterial disease: effect of reconstructive surgery.
    Pernow B, Saltin B, Wahren J, Cronestrand R.
    Scand J Clin Lab Invest Suppl; 1973 Sep; 128():21-5. PubMed ID: 4764586
    [No Abstract] [Full Text] [Related]

  • 6. Effects of inspiratory loading on 31phosphorus magnetic resonance spectroscopy of the inspiratory intercostal muscles in normal humans.
    Lopata M, Onal E, Aronson RM, Carley DW.
    Trans Assoc Am Physicians; 1988 Sep; 101():203-11. PubMed ID: 3269679
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of a nucleotide-nucleoside mixture on ischemic muscle metabolism in patients with stage II peripheral arterial occlusive disease. MR spectroscopic and biochemical analytic results].
    Rexroth W, Huber KH, Rädle J, Semmler W, van Kaick G.
    Vasa; 1994 Sep; 23(2):98-108. PubMed ID: 8036845
    [Abstract] [Full Text] [Related]

  • 8. MRI and MRS of the skeletal muscle.
    Träber F, Kaiser WA, Reiser MF, Nägele M.
    Bildgebung; 1992 Sep; 59(3):156-8. PubMed ID: 1422001
    [Abstract] [Full Text] [Related]

  • 9. Muscle metabolism in patients with peripheral vascular disease investigated by 31P nuclear magnetic resonance spectroscopy.
    Hands LJ, Bore PJ, Galloway G, Morris PJ, Radda GK.
    Clin Sci (Lond); 1986 Sep; 71(3):283-90. PubMed ID: 3757432
    [Abstract] [Full Text] [Related]

  • 10. [Metabolic studies of muscles and blood in ergometrically stressed patients with arterial occlusive disease].
    Nissen P, Alexander K, Maass U.
    Verh Dtsch Ges Kreislaufforsch; 1977 Sep; 43():176. PubMed ID: 613562
    [No Abstract] [Full Text] [Related]

  • 11. Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopy.
    Arnold DL, Taylor DJ, Radda GK.
    Ann Neurol; 1985 Aug; 18(2):189-96. PubMed ID: 4037759
    [Abstract] [Full Text] [Related]

  • 12. P31-NMR studies of muscle in patients with venous insufficiency.
    Taheri SA, Pollack L, Loomis R.
    Int Angiol; 1987 Aug; 6(1):95-8. PubMed ID: 3624954
    [Abstract] [Full Text] [Related]

  • 13. [The value of 31 P nuclear magnetic resonance spectroscopy in follow up of Fontaine stage IIb peripheral arterial occlusive disease].
    Scheffler P, Leipnitz G, Gross J, Kuhn W, Windeck P.
    Vasa Suppl; 1991 Aug; 33():318-9. PubMed ID: 1788734
    [Abstract] [Full Text] [Related]

  • 14. In vivo P-NMR spectroscopy: muscle energy exchange in paramyotonia patients.
    Lehmann-Horn F, Höpfel D, Rüdel R, Ricker K, Küther G.
    Muscle Nerve; 1985 Sep; 8(7):606-10. PubMed ID: 4047092
    [Abstract] [Full Text] [Related]

  • 15. [Topical nuclear magnetic resonance--a non-invasive probe for biochemical measurements in living organisms].
    Aue WP.
    Radiologe; 1983 Aug; 23(8):357-60. PubMed ID: 6578539
    [Abstract] [Full Text] [Related]

  • 16. Phosphorus magnetic resonance spectroscopy: a noninvasive technique for the study of occlusive arterial leg disease and peripheral vasodilator therapy.
    Wahl DG, Simon JP, Robin B, Walker P, Jouanny P, Escanye JM, Paille F, Schmidt C, Brunotte F, Robert J.
    Angiology; 1994 May; 45(5):367-76. PubMed ID: 8172384
    [Abstract] [Full Text] [Related]

  • 17. Prerequisites and initial experience for the noninvasive routine evaluation of viability of experimental and human organ transplants by magnetic resonance spectroscopy.
    Henze E, Lietzenmayer R, Kunz R, Schnur G, Clausen M, Schoser K, Beger HG, Adam WE, Ankele J, Beck C.
    Transplant Proc; 1990 Oct; 22(5):2404-8. PubMed ID: 2219413
    [No Abstract] [Full Text] [Related]

  • 18. Brain death-induced alterations in myocardial workload and high-energy phosphates: a phosphorus 31 magnetic resonance spectroscopy study in the cat.
    Brandon Bravo Bruinsma GJ, Nederhoff MG, te Boekhorst BC, Bredée JJ, Ruigrok TJ, van Echteld CJ.
    J Heart Lung Transplant; 1998 Oct; 17(10):984-90. PubMed ID: 9811406
    [Abstract] [Full Text] [Related]

  • 19. Assessment of muscular metabolism in peripheral arterial occlusive disease using 31P nuclear magnetic resonance spectroscopy. Comparison with metabolite concentrations in femoral blood.
    Rexroth W, Semmler W, Gückel F, Stadtlander M, Weicker H, Hild R, van Kaick G.
    Klin Wochenschr; 1989 Aug 17; 67(16):804-12. PubMed ID: 2796250
    [Abstract] [Full Text] [Related]

  • 20. [Modification of ischemia and reperfusion damage of skeletal muscles with allopurinol: in vivo 31P MR spectroscopy of the posterior limb of the rat].
    Gürke L, Marx A, Erhard P, Sutter PM, Landmann J, Heberer M.
    Helv Chir Acta; 1993 Jun 17; 59(5-6):877-80. PubMed ID: 8376157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.